| FFRTX | RFRAX | FFRTX / RFRAX | |
| Total Expense Ratio | 1.02 | 1.01 | 101% |
| Annual Report Gross Expense Ratio | 1.02 | 1.07 | 95% |
| Fund Existence | 26 years | 20 years | - |
| Gain YTD | 1.895 | 1.391 | 136% |
| Front Load | 3% | 3% | 92% |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | 500 | 5000 | 10% |
| Net Assets | 14.4B | 666M | 2,162% |
| Annual Yield % from dividends | 6.75 | 6.50 | 104% |
| Returns for 1 year | 4.72 | 4.09 | 115% |
| Returns for 3 years | 22.73 | 22.72 | 100% |
| Returns for 5 years | 31.71 | 27.65 | 115% |
| Returns for 10 years | 62.23 | 56.44 | 110% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VGHCX | 211.09 | 5.96 | +2.91% |
| Vanguard Health Care Inv | |||
| JEUIX | 19.59 | 0.13 | +0.67% |
| Janus Henderson Global Sust Eq I | |||
| LMCPX | 36.35 | 0.05 | +0.14% |
| Lord Abbett Mid Cap Stock P | |||
| MLNIX | 28.27 | -0.03 | -0.11% |
| Morgan Stanley Instl Glbl Concntr I | |||
| GERAX | 13.77 | -0.30 | -2.13% |
| Goldman Sachs Em Mkts Eq Insghts A | |||